Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001415889-24-008260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2024-03-14 | ALXO | Lettmann Jason | CEO, Dir | P - Purchase | $11.31 | +4,400 | 171.6K | +3% | +$49.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | P | A | 4,400 | $11.31 | 171,620 | D | — | — |